|1||Active, not recruiting||
Phase 1 Follow-on Study of AAV2-hRPE65v2 Vector in Subjects With Leber Congenital Amaurosis (LCA) 2
|2||Active, not recruiting||
Safety and Efficacy Study in Subjects With Leber Congenital Amaurosis
† Study has passed its completion date and status has not been verified in more than two years.